Research Topic · Peer-Reviewed

SARS-CoV

SARS-CoV (severe acute respiratory syndrome coronavirus) is the zoonotic, positive-sense single-stranded RNA coronavirus that caused the Severe Acute Respiratory Syndrome (SARS) outbreak of 2002–2003. Transmitted to humans from animal reservoirs, it is a member of the family Coronaviridae and displays the distinctiv…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 24× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

SARS-CoV (severe acute respiratory syndrome coronavirus) is the zoonotic, positive-sense single-stranded RNA coronavirus that caused the Severe Acute Respiratory Syndrome (SARS) outbreak of 2002–2003. Transmitted to humans from animal reservoirs, it is a member of the family Coronaviridae and displays the distinctive crown-like fringe of spike (S) glycoprotein projections common to coronaviruses. SARS-CoV is historically significant both as the first coronavirus to cause a major international epidemic of severe respiratory disease and as a close phylogenetic relative of SARS-CoV-2, the agent of COVID-19, making it an important reference point for comparative virology. Study of SARS-CoV centres on its genome organization, evolutionary relationships to other human and animal coronaviruses, the structure and function of its spike protein in mediating host-cell entry, and its mechanisms of pathogenesis. Comparative analyses of spike glycoprotein-coding gene sequences illuminate how SARS-CoV relates to SARS-CoV-2 and to animal coronaviruses, informing understanding of cross-species transmission and emergence. Research published under this topic examines viral evolution, transmissibility, immune responses, neutralizing antibodies, candidate therapeutics, and the broader lessons that the original SARS epidemic offers for surveillance of and preparedness against emerging coronavirus threats.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
Exact topic International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538
2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
Exact topic International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373

How this research is being cited

The 12 articles above have been cited 24 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on SARS-CoV, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.